6 Meridian’s Haemonetics HAE Stock Holding History

6 Meridian’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,872	Closed	-$222K	–	422
2020 Q4	$222K	Buy	+1,872	New	+$202K	0.02%	260
2018 Q1	–	Sell	-10,514	Closed	-$611K	–	456
2017 Q4	$611K	Buy	+10,514	New	+$554K	0.07%	161

Other funds holding HAE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

6 Meridian's HAE Position: Q1 2021 in Review

6 Meridian sold out of Haemonetics (HAE) in Q1 2021, closing a stake of 1,872 shares — an estimated $222K sold.

6 Meridian first reported a position in HAE in Q4 2017 and held it in 2 quarters. The position peaked at $611K in Q4 2017. 296 funds tracked by Wall St. Rank hold HAE as of Q1 2021.

6 Meridian reported no remaining Haemonetics position as of Q1 2021 after selling out during the quarter.
6 Meridian sold 1,872 Haemonetics shares in Q1 2021, an estimated $222K.
6 Meridian first reported a position in Haemonetics in Q4 2017 and held it in 2 quarters.
6 Meridian's Haemonetics position peaked at $611K in Q4 2017.
296 funds tracked by Wall St. Rank held Haemonetics as of Q1 2021.

Based on 6 Meridian's 13F filing for Q1 2021, filed 22 Apr 2021.